What Advances Have Been Made in TB Drug Development?
Recent advances in TB drug development include the introduction of bedaquiline and delamanid, both of which have shown efficacy against drug-resistant TB strains. These drugs have been subjected to rigorous toxicological evaluation to ensure their safety in humans. Innovations in drug delivery systems, such as nanoparticle-based formulations, are also being explored to enhance drug efficacy and reduce systemic toxicity.
